SequelSEC

SANUWAVE Health, Inc. SNWV

Surgical & Medical Instruments & Apparatus · CIK 0001417663 · Fiscal year ends 1231

AnnualQuarterlyTTM
Revenue
$44.02M
Fiscal year ended 2026-06-30
Operating income
$1.50M
Fiscal year ended 2026-06-30
Free cash flow
$4.24M
Fiscal year ended 2026-06-30

SANUWAVE Health, Inc. (SNWV) reported revenue of $44.02M and net income of $15.26M for the fiscal year ended 2026-06-30. This page shows 1 annual period of income statement, balance sheet and cash flow figures normalized from SANUWAVE Health, Inc.’s SEC filings, each linked to the filing it came from. It is classified by the SEC under Surgical & Medical Instruments & Apparatus.

Income

SANUWAVE Health, Inc. income by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Revenue$44.02M
Cost of revenue$10.42M
Gross profit$33.60M
Operating income$1.50M
Net income$15.26M
Research & development$2.24M
Weighted-average diluted sharesUnavailable
Pretax incomeUnavailable
Income tax expenseUnavailable
Diluted EPSUnavailable
Selling, general & administrative$28.85M
General & administrative$20.31M
Selling & marketing$8.54M

Balance

SANUWAVE Health, Inc. balance by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Cash & equivalents$9.38M
Total assets$36.60M
Current assets$23.20M
Total liabilities$33.82M
Current liabilities$18.17M
Total equity incl. NCI$2.79M
Temporary (mezzanine) equityUnavailable
Inventory$7.07M
Accounts receivable$5.80M
Goodwill$7.26M
Long-term debtUnavailable
Accounts payable$3.31M

Cash flow

SANUWAVE Health, Inc. cash flow by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Operating cash flow$5.22M
Capital expenditures$978.00K
Investing cash flow$4.15M
Financing cash flow-$8.49M
Net change in cash$880.00K
Stock-based compensation$5.89M
Common dividends paidUnavailable
Common share repurchasesUnavailable
Depreciation & amortization$1.06M

Derived

SANUWAVE Health, Inc. derived by fiscal year, in US dollars, normalized from SEC filings.
Metric2026-06-30
Free cash flow$4.24M
Gross margin76.3%
Operating margin3.4%
FCF margin9.6%
SBC / revenue13.4%
Current ratio1.28x
Revenue YoY growth12.7%
Net margin34.7%
R&D / revenue5.1%
CapEx / revenue2.2%
Long-term debt / equityUnavailable
Effective tax rateUnavailable

Amounts are abbreviated; the exact reported value is carried in each cell. — means unavailable, not zero. Open SNWV in the interactive workspace to inspect any figure back to its filing.

Source filings

10-Q · Filed 2026-08-06View SEC filing
10-Q · Filed 2026-05-12View SEC filing
10-K · Filed 2026-03-26View SEC filing
10-Q · Filed 2025-11-06View SEC filing
10-Q · Filed 2025-08-07View SEC filing
10-Q · Filed 2025-05-08View SEC filing

Companies in the same industry

ADGM AEMD ALUR AMIX ANGO ANIK AORT APYX ARAY ATEC ATRC AURX

Every accounting identity this site checks — the balance sheet, the gross profit bridge and the cash flow statement — reconciles in every period shown.